Nitric oxide and teratogenesis: an update

Area of Science:

• Developmental Biology
• Molecular Biology
• Teratology

Background:

• Nitric oxide (NO), produced by NO synthase (NOS) enzymes, regulates key developmental processes like cell growth, differentiation, and apoptosis.
• Temporal and spatial expression of NOS isoforms in embryonic tissues is critical; disruptions lead to developmental abnormalities.
• Maternal NOS inhibition or in utero NO disruption causes significant embryonic malformations.

Purpose of the Study:

• To investigate the role of nitric oxide (NO) and its synthase (NOS) isoforms in embryonic development and organogenesis.
• To define the specific contributions of different NOS isoforms to developmental defects using knockout mouse models.
• To explore the link between NO dysregulation and teratogen-induced malformations.

Main Methods:

• Utilized maternal treatment with pan NOS inhibitors during organogenesis.
• Examined developmental defects in fetal mice following in utero exposure.
• Generated and analyzed knockout mice lacking specific NOS isoforms (eNOS, iNOS, nNOS).
• Conducted in vitro studies on neural tube closure and NO levels.

Main Results:

• Maternal NOS inhibition caused severe axial skeletal malformations.
• In utero exposure led to vascular-related limb reduction defects.
• eNOS knockout mice exhibited cardiovascular malformations, limb defects, growth reduction, and decreased survival.
• iNOS and nNOS knockout mice showed limited morphological changes.
• In vitro studies indicated optimal NO levels are necessary for neural tube closure.

Conclusions:

• Endogenous nitric oxide (NO) is essential for normal embryonic development and organogenesis.
• Endothelial NOS (eNOS) plays a critical role in cardiovascular and limb development.
• Disruption of NO signaling is implicated in developmental defects caused by environmental teratogens.
• Maintaining optimal NO levels is crucial for preventing congenital malformations.